Skip to main content

Arcus Biosciences

Hayward, United States

Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.

Oct 2025
Post-IPO Equity

Top Investors

Wellington ManagementHillhouse InvestmentForesite CapitalGilead SciencesNovartis

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Arcus Biosciences

Who are Arcus Biosciences's investors?
Arcus Biosciences's investors include Wellington Management, Hillhouse Investment, Foresite Capital, Gilead Sciences, Novartis.
Where is Arcus Biosciences headquartered?
Arcus Biosciences is headquartered in Hayward, United States.
What does Arcus Biosciences do?
Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.
What stage is Arcus Biosciences at?
Arcus Biosciences is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Arcus Biosciences — Funding & Investors." VCBacked, October 30, 2025, https://www.vcbacked.co/company/arcus-biosciences. Accessed July 1, 2026.
APA
VCBacked. (2025). Arcus Biosciences — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/arcus-biosciences
Wikipedia (cite web)
{{cite web |title=Arcus Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/arcus-biosciences |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .